Benzinga Pro offers a real-time newsfeed as headlines break on earnings releases, analyst ratings, rumors, the biggest movers, and many more actionable alerts.

Find Stocks Tailored to Your Trading Interests

benzingaproreview-1-1280x720

acf/call-to-action

<a href="https://share.hsforms.com/1kQ-soZmmTRqplsRXp5Zfpw1npzh">Claim Exclusive Offers</a>

Compare Investing Brokers (USE THIS ONE)

acf/widget-container

acf/compare-products

Plus500 Yield

IBKR Stocks

public.com

Moomoo

Webull

<a href="https://share.hsforms.com/1kQ-soZmmTRqplsRXp5Zfpw1npzh">Claim Exclusive Offers</a>

Compare Crypto Brokers Homepage

Plus500 Crypto

Kraken

Webull Crypto

FxGlory

eToro

Uphold Crypto

Compare Brokers Table – Benzinga.com

Taysha Gene Therapies

Taysha Gene Therapies, Inc. - Common Stock

ACADIA Pharmaceuticals

ACADIA Pharmaceuticals Inc. - Common Stock

Neurogene

Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.

Keith Tapper's

xr:d:DAFzgn8dVBs:2,j:9120197723021318877,t:23110718

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-ratings/">analyst ratings page</a>.



<ul>
<li>BMO Capital analyst Keith Tapper initiated coverage on ACADIA Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACAD#NASDAQ">ACAD</a>) with an Outperform rating and announced a price target of $31. ACADIA Pharmaceuticals shares fell 0.6% to close at $15.50 on Wednesday. <a href="https://www.benzinga.com/quote/ACAD/analyst-ratings">See how other analysts view this stock.</a></li>



<li>Mizuho analyst Wei Fang initiated coverage on Grab Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRAB#NASDAQ">GRAB</a>) with an Outperform rating and announced a price target of $5. Grab shares fell 0.3% to close at $3.51 on Wednesday. <a href="https://www.benzinga.com/quote/GRAB/analyst-ratings">See how other analysts view this stock.</a></li>



<li>Redburn Atlantic analyst Steve Chesney initiated coverage on Vertex Pharmaceuticals Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) with a Buy rating and announced a price target of $545. Vertex Pharmaceuticals shares rose 0.1% to settle at $474.00 on Wednesday. See how other analysts view this stock. <a href="https://www.benzinga.com/quote/VRTX/analyst-ratings">See how other analysts view this stock</a>.</li>



<li>Stephens &amp; Co. analyst Mason Carrico initiated coverage on Hologic, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLX#NASDAQ">HOLX</a>) with an Overweight rating and announced a price target of $87. Hologic shares gained 0.9% to close at $72.27 on Wednesday. <a href="https://www.benzinga.com/quote/HOLX/analyst-ratings">See how other analysts view this stock.</a></li>



<li>Oppenheimer analyst Ian Zaffino initiated coverage on Kyndryl Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KD#NYSE">KD</a>) with an Outperform rating and announced a price target of $33. Kyndryl shares fell 1% to settle at $25.28 on Wednesday. <a href="https://www.benzinga.com/quote/KD/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>



Check This Out: <a href="https://www.benzinga.com/news/24/06/39500574/over-30m-bet-on-this-energy-stock-check-out-these-3-stocks-insiders-are-buying">Over $30M Bet On This Energy Stock? Check Out These 3 Stocks Insiders Are Buying</a>

News

Initiation

Markets

Analyst Ratings

Trading Ideas

ACAD

GRAB

HOLX

VRTX

This Vertex Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Analyst Ratings Newsletter

Don't Miss Your Daily Analyst Rating Email!!!

acf/newsletter-subscription-box

		Buy Now							Get Alert
06/27/2024	TSHA	Buy Now	Taysha Gene Therapies	$2.21	126.24%	→ $5	Initiates	→ Outperform	Get Alert
06/27/2024	ACAD	Buy Now	ACADIA Pharmaceuticals	$16.22	91.12%	→ $31	Initiates	→ Outperform	Get Alert
06/27/2024	NGNE	Buy Now	Neurogene	$36.39	78.62%	→ $65	Initiates	→ Outperform	Get Alert

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Keith Tapper's Stock Ratings

BMO Capital Analyst

Overall Average Return

Smart Score

Overall Average Return Percentile

Number of Ratings

Recent Analyst Stock Rating News